Vitamins B 12 , B 6 , and folic acid converge at the homocysteine metabolic junction where they support the activities of two key enzymes involved in intracellular homocysteine management, methionine synthase (MS) and cystathionine ␤-synthase. The molecular mechanism for the regulation of homocysteine metabolism by B 12 supplementation has been investigated in this study. B 12 supplementation does not alter mRNA or protein turnover rates but induces translational up-regulation of MS by shifting the mRNA from the ribonucleoprotein to the polysome pool. The B 12 -responsive element has been localized by deletion analysis using a reporter gene assay to a 70-bp region located at the 3 end of the 5-untranslated region of the MS mRNA. The cellular consequence of the B 12 response is a 2-and 3.5-fold increase in the flux of homocysteine through the MS-dependent transmethylation pathway in HepG2 and 293 cells, respectively. It is speculated that B 12 -induced up-regulation of MS may have evolved as an adaptive strategy for rapidly sequestering an essential and rare nutrient whose availability may have been limited in the evolutionary history of mammals, a problem that is exacerbated by the absence of this vitamin from the plant kingdom.
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Vitamins B 12 , B 6 , and folic acid converge at the homocysteine metabolic junction where they support the activities of two key enzymes involved in intracellular homocysteine management, methionine synthase (MS) and cystathionine ␤-synthase. The molecular mechanism for the regulation of homocysteine metabolism by B 12 supplementation has been investigated in this study. B 12 supplementation does not alter mRNA or protein turnover rates but induces translational up-regulation of MS by shifting the mRNA from the ribonucleoprotein to the polysome pool. The B 12 -responsive element has been localized by deletion analysis using a reporter gene assay to a 70-bp region located at the 3 end of the 5-untranslated region of the MS mRNA. The cellular consequence of the B 12 response is a 2-and 3.5-fold increase in the flux of homocysteine through the MS-dependent transmethylation pathway in HepG2 and 293 cells, respectively. It is speculated that B 12 -induced up-regulation of MS may have evolved as an adaptive strategy for rapidly sequestering an essential and rare nutrient whose availability may have been limited in the evolutionary history of mammals, a problem that is exacerbated by the absence of this vitamin from the plant kingdom.
Vitamins B 12 , folic acid, and B 6 converge at a single metabolic junction in mammals that is involved in homocysteine detoxification. Elevated levels of homocysteine are a risk factor for cardiovascular diseases (1), neural tube defects (2) , and Alzheimer's disease (3) . It is estimated that up to 40% of the general population at risk for heart diseases may have elevated levels of homocysteine. Despite these significant statistics, our understanding of homocysteine regulation and how nutrients (viz. vitamins) can modulate flux of homocysteine through competing pathways is poor.
Of the three vitamins important for homocysteine metabolism, B 12 has the most limited distribution in nature; it is biosynthesized by some bacteria and is absent from the plant kingdom. In humans, it supports the activities of two known enzymes, the cytoplasmic methionine synthase (MS) 1 and the mitochondrial methylmalonyl-CoA mutase (4, 5) . MS is a housekeeping enzyme that plays an essential function, and knockout of this gene in mice results in embryonic lethality in the homozygous state (6) .
The ability of vitamin B 12 added to the cell culture medium to activate MS was first reported more than three decades ago (7, 8) . It is important to emphasize that in these studies cells were exposed to B 12 supplementation after having been cultured in "normal" rather than B 12 -depleted media. Thus, the induction of MS activity by B 12 was elicited by vitamin supplementation rather than a transition from B 12 -deplete to B 12 -replete medium. Although the molecular basis for this induction was not described, it was suggested that it resulted from conversion of apoenzyme to holoenzyme in the presence of exogenous B 12 (9) . More recently, we have published evidence that ruled out apoenzyme to holoenzyme conversion as a plausible mechanism for B 12 -induced activation of MS and demonstrated that although the steady-state levels of mRNA were unaffected, the MS protein levels increased 2-3-fold (10). These results ruled out transcriptional regulation and suggested that the B 12 effect may be exerted at a translational level.
In principle, the effect of B 12 at a posttranscriptional level could occur by enhanced mRNA or protein stability or by increased translational efficiency. This study was designed to distinguish between these possibilities and to determine whether modulation of MS translation efficiency by B 12 is mediated by an element in the 5Ј-UTR of the mRNA. The physiological relevance of B 12 -dependent gene regulation was demonstrated by the observation that B 12 supplementation resulted in enhanced flux of homocysteine through the MS-dependent transmethylation pathway in cultured cells. Cell Culture Conditions-Cells were grown in Eagle's minimum essential medium supplemented with 10% fetal bovine serum and maintained at 37°C, 5% CO 2 . B 12 derived from fetal bovine serum is present at an estimated final concentration of ϳ125 pM in this medium (9) . For B 12 induction studies, the cells were grown to 60 -80% confluency, and fresh Eagle's minimum essential medium supplemented with 5 mg/liter hydroxocobalamin (or 3.6 M final concentration) was added. For Western and Northern analyses of MS and for the luciferase reporter studies, cells were harvested from 100-mm plates. [ 14 CH 3 ]H 4 folate incorporation was examined in cells grown in 60-mm plates. Protein and mRNA turnover experiments were performed in the presence of puromycin and actinomycin, respectively (at final concentrations of 10 g/ml each), added to the cell culture medium. * This research was supported by National Institutes of Health Grant DK64959 and by a predoctoral fellowship from the American Heart Association (Heartland Affiliate) (to S. O.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
EXPERIMENTAL PROCEDURES
Materials
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Western Blot Analysis of MS-Western blot analysis was performed as described previously (10) . The bands were quantitated by densitometry using NIH image software. To ensure equal loading, the membranes were also probed with an antibodies against Propionibacterium shermanii methylmalonyl-CoA mutase.
Northern Blot Analysis of MS mRNA-Total RNA was isolated using the Trizol reagent (Invitrogen) according to the manufacturer's protocol, and Northern blots were performed as described previously (10) . The membrane was then exposed to Biomax film (Eastman Kodak Co.) at Ϫ70°C and developed, and the bands were quantified by densitometry using NIH image software. The band intensities were normalized versus 18 S ribosomal RNA in the same samples.
Polysome Analysis-Polysome analysis was performed essentially as described (11) . Briefly, four 100-mm dishes of COS-1 cells at subconfluent density were used for each polysome distribution analysis. Cells were washed 3 times with ice-cold phosphate-buffered saline containing 100 g/ml cycloheximide, removed using a cell scraper, and lysed in polysome lysis buffer (100 mM KCl, 5 mM MgCl 2 , 10 mM HEPES (pH 7.4), 100 g/ml cycloheximide, 0.5% Nonidet P-40, 20 units/ml RNasin (Promega). Nuclei were pelleted by centrifugation at 12,000 ϫ g at 4°C for 5 min. Equivalent amounts of RNA were loaded onto each 15-50% (w/v) linear sucrose gradient. Gradients were centrifuged at 39,000 rpm for 2.5 h at 4°C in a Beckman SW41 rotor, and fractions were collected with an ISCO model 640 density gradient fractionator (ISCO, Inc. Lincoln, NE). Total RNA from each fraction was extracted with phenol/ chloroform and reverse transcription-PCR was performed using the SuperScript TM kit (Invitrogen). cDNA was obtained using gene-specific primers. For MS, a fragment of 340 bases from the 5Ј-UTR was amplified. For methylmalonyl-CoA mutase, a fragment encompassing the coding sequence was amplified. Products of the reverse transcription-PCR reactions were separated on agarose gels and visualized with ethidium bromide staining. Control experiments were conducted to ensure that the reverse transcription-PCR reactions were in the linear range of amplification by examining the dependence of the product intensity on the number of amplification cycles. Based on this analysis, 25 and 30 cycles of amplification were employed with the MS and methylmalonyl-CoA mutase primers, respectively. The bands were quantified by densitometry using Quantity One (Bio-Rad) software. Three independent experiments were performed.
Luciferase and CAT Reporter Constructs-A clone containing the 5Ј-UTR of MS was generously provided by Dr. Barry Shane (University of California, Berkeley). To follow the effects of the 5Ј-UTR of MS on a downstream reporter gene, the full-length 5Ј-UTR of MS or the second half (bases 173-394) were cloned upstream of the luciferase-or CATcoding regions in the pGL3 or pCAT3-Promoter vectors (Promega), respectively. Pairs of primers for amplification of the full-length 5Ј-UTR of MS and for the first and second halves of the 5Ј-UTR of MS were designed as follows: full-length 5Ј-UTR sense primer, 5Ј-CCCAAGCT-TAAAGGTTCTAAAT-3Ј, and antisense primer, 5Ј-CATGCCATGGTT-GTCGAGTCTC-3Ј; first half of 5Ј-UTR antisense primer, 5Ј-CATGC-CATGGGACCCCGAAAGCCCGCAGCG-3Ј, and second half of 5Ј-UTR sense primer, 5Ј-CCCAAGCTTCCAGCAGTTGCCGCGCCCAG-3Ј.
HindIII and NcoI restriction sites were engineered into the 5Ј and the 3Ј primers, respectively. After PCR amplification, the DNA fragments were directly cloned into the HindIII/NcoI sites of the pGL3 promoter vector (Promega) so that the MS 5Ј-UTR was followed by the luciferase start codon. The only difference was a cytosine inserted between the MS 5Ј-UTR and the luciferase start codon that resulted from the creation of the NcoI site. The pGL3 promoter vector contains an SV40 promoter close to the HindIII site so that 20 bases are added upstream of the MS 5Ј-UTR in the resulting reporter gene transcript. All PCR reactions were performed using the high fidelity Pfu polymerase (Stratagene) to minimize the risk of introducing unwanted mutations. The sequences of all the constructs were verified by nucleotide sequence determination at the Center for Biotechnology Core Facility (University of Nebraska, Lincoln, NE). All the clones had a single base difference (a G instead of A at position 161) as compared with the reported MS 5Ј-UTR in GenBank TM (accession number U73338). Deletion constructs containing 340, 270, 140, and 70 bases of the 5Ј-UTR of MS were generated by PCR and cloned into the pGL3-Promoter vector using the HindIII/NcoI sites. For PCR amplification of these fragments, the antisense primer described above was used. The sense primers were designed as follows: fragment 54 -394, 5Ј-CCCAAGCTTTGCCGGTTTTCTCTTGGGTC-3Ј; fragment 124 -394, 5Ј-CCCAAGCTTCTAGGCCGACACCAAGGACT-3Ј; fragment 173-394, 5Ј-CCCAAGCTTAGCCAACGGCAGGCGTCAAA-3Ј; fragment 254 -394, 5Ј-CCCAAGCTTTTGGCCGTCGTCACCTGTGG-3Ј.
To determine the effects of the 5Ј-UTR on a second reporter, the full-length 5Ј-UTR of MS (bases 1-394) and the second half (bases 173-394) were subcloned into the pCAT3-Promoter vector (Promega) using the same cloning strategy described above for the luciferase reporter construct.
Transient Transfection and Reporter Assays-Transfection was performed using the LipofectAMINE reagent (Invitrogen) for 293 cells or the GeneJammer (Stratagene) for HepG2 and COS-1 cells. Briefly, 15-20 g of plasmid DNA was mixed with 80 -100 l of transfection reagent according to the manufacturer's specifications, and the mixture was added to 100-mm plates. 24 h after transfection, B 12 was added to half of the plates. At the end of the incubation, two-thirds of each plate were scraped, and cells were centrifuged and saved for total RNA isolation. The remaining one-third of the cells were lysed using the protocol supplied with the luciferase assay system (Promega). The luciferase activity was measured using a luminometer (average of three readings). CAT activity was measured according to the vendor's protocol (Promega). Both luciferase and CAT activities were normalized to total protein concentration in each sample. To account for differences in transfection efficiency (and therefore transcription) between plates, the luciferase and CAT activities were additionally normalized to luciferase and CAT mRNA levels, respectively, as determined by Northern blot analysis.
Northern Blot Analysis of Luciferase and CAT mRNA-Total RNA was isolated using the RNAqueaous kit (Ambion) according to the manufacturer's protocol, and Northern blots were performed as described previously (10) . 32 P-Labeled probes consisting of a DNA fragment encompassing the entire luciferase or CAT open reading frame were purified and labeled with random primers using the Rediprime kit (Amersham Biosciences). Bands were quantified by densitometry using Quantity One (Bio-Rad) software. The band intensities were normalized to the 18 S ribosomal RNA band in each sample to correct for variations in loading quantities.
Measurement (12) . Cells were incubated for 30 min in methionine-deficient media (Dulbecco's modified Eagle's medium lacking methionine and supplemented with 100 M homocysteine and 9 M folic acid). 5 Ci of [ 14 CH 3 ]-H 4 folate (Amersham Biosciences, 57 mCi/mmol; final medium concentration, 53 M) was added, and incubation was continued for an additional 2 h. Cells were then washed three times with phosphatebuffered saline and suspended in 1 ml of phosphate-buffered saline. 100 l from each sample was set aside for protein concentration determination. The remaining suspension was centrifuged, and proteins were precipitated with 500 l of 5% trichloroacetic acid, incubated on ice for 20 min, heated at 80°C for 30 min, and then cooled on ice for 30 min. The protein precipitate was washed 3 times with 5% trichloroacetic acid and then suspended in 200 l of 3 M NaOH, and the amount of radioactivity was measured by liquid scintillation counting. The radioactive content was normalized to total protein concentration in each sample.
Statistical Analysis-Each experiment was repeated at least three times. Statistical analysis was performed using one-way analysis of variance (Microcal Origin software), and results were considered significant if the p value was Ͻ0.05. Each of the methods employed in this study, viz. densitometric analysis of Western and Northern blots and luciferase reporter assays, have errors that are inherently associated with them, which renders measurement of 2-fold effects of the kind reported in this study challenging. However, it should be noted that in all cases we have examined the relative effect of the variable, i.e. B 12 supplementation, on experiments run in parallel in unsupplemented media. 12 on MS mRNA Stability-The influence of B 12 on MS mRNA stability was assessed in 293 cells treated with the transcription inhibitor actinomycin D. The relative steadystate MS mRNA levels were followed by Northern blot analysis as shown in Fig. 1 . Two messages corresponding in size to ϳ7 and 10 kb are seen in all human tissues that have been examined so far (13) . Our results show that rate of MS mRNA turnover is unaffected by B 12 supplementation of the medium and that the half-life of the message is Ϸ19 h. These results indicate the B 12 induction of MS activity is not exerted at the level of increased mRNA stability. 12 on MS Stability-It is not uncommon for protein stability to be enhanced by the binding of its cofactor, and in fact rat MS has been shown to be stabilized by B 12 (14) . To determine whether B 12 supplementation affected the steadystate turnover of MS, we examined the relative levels of this protein by Western blot analysis in 293 cells treated with the translation inhibitor puromycin (Fig. 2A) . The turnover rate of MS in the presence and absence of exogenous B 12 was the same (half-life Ϸ12 h) within experimental error excluding a role for B 12 in modulating MS stability under these conditions (Fig.  2B) . This is consistent with our earlier observations that MS is present predominantly (Ͼ80%) in the holoenzyme form in 293 cells grown in the presence of normal Eagle's minimum essential medium (10) . In addition, we have reported that the relative proportion of the holoenzyme form is unchanged under conditions of B 12 supplementation, although the enzyme activity is increased 2.5-fold under these conditions (10) .
RESULTS
Effect of B
Effect of B 12 on MS Polysomes-We analyzed the influence of B 12 on translation of MS by examining the polysomal association of mRNAs in the presence and absence of B 12 . As shown in Fig. 3, B 12 supplementation elicits a 2.5-3-fold increase in the amplitude of MS polysomes and a corresponding decrease in the proportion of MS mRNA associated with the ribonucleoprotein fraction. These results are consistent with activation of MS translation by B 12 supplementation. The magnitude of the increase in MS polysomes is consistent with the previously reported 3.8-fold increase in MS activity induced by B 12 in COS-1 cells (10) . As a control, the distribution of methylmalonyl-CoA mutase, whose activity is not affected by B 12 supplementation, was determined under the same conditions. The amplitude of methylmalonyl-CoA mutase message in the polysomes and ribonucleoprotein pools was unchanged, revealing a specific effect of B 12 supplementation on MS mRNA.
Changes in the polysome density (i.e. number of ribosomes per mRNA) or amplitude (i.e. number of actively translated mRNAs) are diagnostic of the status of translation from a given message. Activation of protein synthesis can occur via increased recruitment of ribosomes to the mRNA being translated. Alternatively, activation can result due to an increase in the number of mRNA molecules undergoing translation due to a shift in the equilibrium between the inactive (translation suppressed, ribonucleoprotein) and active (translation active, polysome) pools (15) . bases) and displays a high potential for formation of secondary structures, suggestive of a role in regulation of translation. Reporter constructs were initially generated with either the full-length leader sequence or with the second half (173-394 bases) of the 5Ј-UTR inserted upstream of the luciferase or CAT reporter gene (Fig. 4) .
Role of the 5Ј-UTR in Mediating B 12 -dependent Increase in Translational Efficiency
The respective vectors lacking the 5Ј MS-UTR served as one set of controls. Both the full-length 5Ј-UTR of MS and the second half increased translation of the heterologous reporter gene as assessed by the ratio of the activity of the reporter to its own mRNA levels. The presence of the full-length 5Ј-UTR of MS between the SV40 promoter and the luciferase open reading frame increased the translational efficiency of luciferase in 293 cells ϳ7-fold, whereas the presence of the second half of the 5Ј-UTR increased translational efficiency ϳ2-fold as compared with the pGL3-Promoter vector alone (not shown). The increase in reporter activity upon insertion of the 5Ј MS-UTR could be due to the presence of other regulatory elements in this region, including two upstream open reading frames and the possible existence of an internal ribosome entry sequence element affording cap-independent translation initiation. 2 The roles of these elements in regulating MS translation and their interactions with B 12 are under investigation in our laboratory.
To determine whether the B 12 effect could be observed in the reporter assays and to exclude a cell-specific response, luciferase activity was determined after transient transfection in two cells lines, HepG2 and 293, 24 h after exposure to B 12 (or an equivalent volume of medium in controls). To account for variations in transfection efficiency, the luciferase activities were normalized to the luciferase mRNA levels determined by Northern blot analysis, and equal loading of RNA was confirmed by quantitation of the 18 S rRNA in these samples (Fig.  4) . In both 293 (Fig. 4A) and HepG2 (not shown) cells, the presence of B 12 induced an increase in luciferase activity with the full-length and second half of the leader sequence. Similarly, in COS-1 cells, a 1.2-and 2.9-fold enhancement of CAT reporter activity was observed with B 12 when the full length and the second half of the 5Ј-UTR respectively, were present (Fig. 4B) .
In all three cell lines the increase in reporter activity induced by B 12 was lower than the increase in MS activity (2.5-, 3.8-, and 13.7-fold increase in 293, COS-1, and HepG2 cells, respectively) reported previously (10) . The difference may be attributed to the use of transient transfections in which the full extent of induction is missed or to the boundaries of the B 12 -responsive element extending beyond those of the 5Ј leader used in the present constructs or to long distance interactions with elements that are missing in the reporter constructs. These will be explored in future investigations.
Localization of B 12 -responsive Element-A set of nested deletions extending from the 3Ј end of the 5Ј-UTR were constructed, and their ability to confer responsiveness to B 12 in the luciferase reporter construct was tested in COS-1 cells (Fig. 5) . With each deletion construct, the luciferase activity was compared in the presence and absence of B 12 supplementation to the medium. These experiments localized the B 12 -responsive element to a 70-bp region extending from the 3Ј end of the 5Ј-UTR. It is interesting to note that deletion of the upstream sequences in the 5Ј-UTR resulted in a small increase in the magnitude of the B 12 effect, as seen in the constructs starting from bp 254 and 324.
B 12 Supplementation Enhances Flux Through the Transmethylation Pathway-The effect of B 12 -induced increase in MS levels on the flux of homocysteine through the transmethylation pathway was examined by measuring incorporation of [ 14 CH 3 ]-H 4 folate into proteins. CH 3 -H 4 folate is a substrate for only one known enzyme, B 12 -dependent MS, which transfers the methyl group to homocysteine to give methionine (Fig. 6A) . B 12 supplementation resulted in a 2-3.5-fold increase in incorporation of radiolabel into proteins in HepG2 and 293 cell lines (Fig. 6B) . Three other B 12 forms, cyano-, deoxyadenosyl-and methylcobalamin, were equally efficacious in eliciting enhanced flux through the MS-dependent transmethylation pathway (not shown). These results support a physiological relevance for the role of B 12 supplementation in increasing flux through the transmethylation pathway and, therefore, in intracellular homocysteine clearance. to heme levels. Specific translational control may be achieved by one of a variety of mechanisms including (i) autoregulation via binding of the encoded protein to its mRNA as in thymidylate synthase and dihydrofolate reductase (16 -18), (ii) by trans-regulatory factors such as the iron-responsive elementbinding protein involved in ferritin expression (19) or a redoxsensitive protein that binds to a translational enhancer in the 3Ј-UTR of manganese superoxide dismutase (20) , or (iii) by a short upstream open reading frame in the 5Ј-UTR as in ornithine and S-adenosylmethionine decarboxylases (21) .
The response of human MS mRNA to the presence of a nutritional cofactor, B 12 , appears to be a novel example of specific translational control, since the other B 12 enzyme found in humans, methylmalonyl-CoA mutase, is unaffected (10). The results reported here rule out a role for B 12 in influencing the rate of MS mRNA or protein turnover (Figs. 1 and 2 ), and together with our earlier results, which excluded conversion of preexisting apoenzyme to holoenzyme as a plausible mechanism (10), implicate translational regulation. This model is further supported by a B 12 -induced increase in the amplitude of MS mRNA polysomes with a corresponding decrease in the ribonucleoprotein fraction, which suggests alleviation of translational inhibition or "unmasking" of existing MS mRNAs by the cofactor.
The human MS mRNA is Ͼ7 kb long with a 3.8-kb open reading frame that is hemmed in by a 394-base-long 5Ј-UTR and an ϳ3-kb-long 3Ј-UTR (13, 22) . In general, long 5Ј-UTRs exceeding the average length of 100 -140 nucleotides and exhibiting the potential for stable secondary structure formation are deemed to be important in translational regulation. These considerations guided our decision to initially focus on interrogating the role, if any, of the 5Ј-UTR in modulating the response of human MS mRNA to B 12 .
The extent of translational modulation by the cofactor is modest and varies between 2-and 3-fold in most cell lines that we have tested (10) and leads to an up-regulation rather than repression, which is more commonly observed in examples of translational control of gene expression. Luciferase and CAT reporter constructs implicate the importance of sequences in the 3Ј end of the 5Ј-UTR in modulating the B 12 response (Fig.  4) . This stretch of the human MS mRNA is predicted to form extensive secondary structures (Fig. 7) . The ϳ2-3-fold enhancement of MS translational efficiency by B 12 , albeit modest, is not unexpected for MS, which is a housekeeping enzyme. In another folate cycle enzyme, serine hydroxymethyltransferase, ferritin was reported to increase translation efficiency 1.14 -2.16-fold in reporter constructs containing the 5Ј-UTR (24) . The magnitude of changes for most genes involved in energy metabolism and biosynthesis appears to be ϳ2-fold, as revealed by a global analysis of gene profiles associated with aging (23) .
Recent reports reveal inhibition of translation of genomic RNA in the hepatitis C virus by vitamin B 12 (25) . Toe-printing studies reveal that the vitamin stalls initiation by trapping the 80 S ribosomal complexes on the internal ribosome entry site element (26) . Translational regulation by B 12 has also been documented in prokaryotes, where it represses the btuB gene involved in B 12 transport in Escherichia coli and Salmonella typhimurium and the cob biosynthesis operon in S. typhimurium (for review, see Ref. 27) . In contrast to the situation observed with the human gene, the bacterial response is specific for adenosylcobalamin and represents classic feedback regulation for both the transport and synthesis pathways when exogenous B 12 levels are high. The proposed model involves long range interactions between a translational enhancer in the 5Ј-UTR and the region preceding the Shine-Dalgarno sequence, which promotes initiation in the absence of B 12 (28) . In the presence of B 12 , the conserved "B 12 box" interacts with the translational enhancer, relieving the long distance interactions and promoting secondary structure formation in the region encompassing the Shine-Dalgarno sequence, thereby inhibiting initiation. Adenosylcobalamin has been shown to specifically inhibit ribosome binding to the btuB RNA (29) . A similar mode of regulation has been proposed for other bacterial vitamin biosynthesis genes including thiamin (30) and riboflavin (31) .
Regulatory proteins that bind to adenosylcobalamin have not been identified in prokaryotes despite intensive efforts, raising the possibility that elements in the mRNAs are the direct sensors of this nutrient. Although this issue has not yet been explored in the eukaryotic system reported in this study, it is FIG. 7 . Analysis of RNA sequence in the second half of the 5-UTR of MS mRNA. Predicted secondary structure of the human 5Ј-UTR as analyzed by M-fold (www.bioinfo.rpi.edu/applications/mfold). The structures obtained contained several regions of stable base pairing leading to a complex pattern of stem loop structures. The arrows indicate the beginning and end of the 5Ј-UTR. The boxed structure is formed by the last 70 bases in the 5Ј-UTR, and the same secondary structure is predicted to be retained in all of the deletion constructs described in Fig. 5 that span this region (not shown).
interesting to note that RNA aptamers selected for very high and specific binding of cyanocobalamin are known (32) . The structure of one of these aptamers has revealed the basis of the specificity that underlies the high affinity (K d ϭ 90 nM) and represents one of the tightest aptamer-small molecule interactions that has been characterized (32) .
Although the existence of B 12 -induced translational repression in prokaryotes can be rationalized from the standpoint of metabolic economy, the advantage of translational up-regulation in mammals is less obvious. One possibility is that the availability of B 12 has been limited through much of our evolutionary history, a problem exacerbated by the absence of this vitamin from the plant kingdom. MS is an essential gene, as evidenced by the embryonic lethal phenotype of MS null mice (6) , and is absolutely dependent on B 12 for its activity. The B 12 -independent MS found in some bacteria and in plants is absent in mammals. It is striking that the known B 12 -binding proteins and B 12 -dependent enzymes found in mammals bind their cofactor avidly, in contrast to many prokaryotic enzymes such as glutamate mutase (33) . Indeed, one of the tightest protein-ligand interactions that have been measured is for chicken haptocorrin, which displays a binding constant for B 12 of 10 16 M Ϫ1 (34) . It is possible then that translational up-regulation of MS by B 12 represents an evolutionary adaptation for rapid and efficient sequestration of a rare nutrient, since increased steadystate levels of MS would lead to increased intracellular B 12 concentrations. The demonstration that B 12 added to cells grown in normal medium leads to enhanced flux through the transmethylation pathway suggests a beneficial role for B 12 supplementation. The increased incorporation of radioactivity from [ 14 CH 3 ]-H 4 folate to proteins (Fig. 6B) in B 12 -supplemented medium suggests the potential value of such an intervention in homocysteine-lowering clinical trials by a molecular mechanism that has previously not been recognized.
